Hepatitis C Virus Infection: Host–Virus Interaction and Mechanisms of Viral Persistence

Author:

Chigbu DeGaulle,Loonawat Ronak,Sehgal Mohit,Patel Dip,Jain PoojaORCID

Abstract

Hepatitis C (HCV) is a major cause of liver disease, in which a third of individuals with chronic HCV infections may develop liver cirrhosis. In a chronic HCV infection, host immune factors along with the actions of HCV proteins that promote viral persistence and dysregulation of the immune system have an impact on immunopathogenesis of HCV-induced hepatitis. The genome of HCV encodes a single polyprotein, which is translated and processed into structural and nonstructural proteins. These HCV proteins are the target of the innate and adaptive immune system of the host. Retinoic acid-inducible gene-I (RIG-I)-like receptors and Toll-like receptors are the main pattern recognition receptors that recognize HCV pathogen-associated molecular patterns. This interaction results in a downstream cascade that generates antiviral cytokines including interferons. The cytolysis of HCV-infected hepatocytes is mediated by perforin and granzyme B secreted by cytotoxic T lymphocyte (CTL) and natural killer (NK) cells, whereas noncytolytic HCV clearance is mediated by interferon gamma (IFN-γ) secreted by CTL and NK cells. A host–HCV interaction determines whether the acute phase of an HCV infection will undergo complete resolution or progress to the development of viral persistence with a consequential progression to chronic HCV infection. Furthermore, these host–HCV interactions could pose a challenge to developing an HCV vaccine. This review will focus on the role of the innate and adaptive immunity in HCV infection, the failure of the immune response to clear an HCV infection, and the factors that promote viral persistence.

Funder

National Institutes of Health

Publisher

MDPI AG

Subject

General Medicine

Reference237 articles.

1. Hepatitis B and C virus hepatocarcinogenesis: Lessons learned and future challenges

2. Hepadnaviruses and hepatocellular carcinoma (HCC);Robinson;Cancer Detect. Prev.,1989

3. Hepatitis Bhttp://www.who.int/news-room/fact-sheets/detail/hepatitis-b

4. Hepatitis Chttp://www.who.int/news-room/fact-sheets/detail/hepatitis-c

5. Hepatitis B Progressionhttps://www.hepmag.com/basics/hepatitis-b-basics/hepatitis-b-progression

Cited by 81 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Hepatitis C virus;Molecular Medical Microbiology;2024

2. HCV and HCC Tango—Deciphering the Intricate Dance of Disease: A Review Article;International Journal of Molecular Sciences;2023-11-07

3. A Synopsis of Hepatitis C Virus Treatments and Future Perspectives;Current Issues in Molecular Biology;2023-10-11

4. Progressive dysfunction of the immune system as a factor preventing recoverable regeneration of the liver in chronic fibrosing diseases;Zhurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia»;2023-10-11

5. An Insight into Hepatitis C Virus: In Search of Promising Drug Targets;Current Drug Targets;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3